| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regular Article |
, in Placentas from Women with Preeclampsia1
a Departments of Obstetrics, Gynecology, and Reproductive Sciences and of Cell Biology and Physiology, University of Pittsburgh School of Medicine and Magee-Womens Research Institute, Pittsburgh, Pennsylvania 15213
ABSTRACT
Transcription factors orchestrate the development of extraembryonic tissues. Because placental hypoxia likely plays an important role in both normal and abnormal placentation, we have been investigating the hypoxia-inducible transcription factors (HIFs) in the human placenta. In this report, we focus on the placentas from women with preeclampsia. Because the placenta is a large, heterogeneous organ, we employed a systematic and unbiased approach to placental sampling, and our results are based on the analyses of eight biopsy sites per placenta. We observed no significant differences in HIF-1
or -2 mRNA expression between normal term and preeclamptic placentas. Nor was HIF protein expression significantly different, with the notable exception of HIF-2, which, on average, was increased by 1.7-fold in the preeclamptic placentas (P < 0.03 vs. normal term placentas). Considering all 48 paired placental biopsy sites (eight sites each for six normal term and six preeclamptic placentas), HIF-2 protein levels in the preeclamptic placentas exceeded those in the normal term placentas in 39, or 81%, of the paired sites (P < 0.0013). The HIF-2 immunoreactivity was mainly located in the nuclei of the syncytiotrophoblast and fetoplacental vascular endothelium in the preeclamptic villous placenta. To control for the earlier gestational age of the preeclamptic placentas, an additional group of placentas from preterm deliveries without preeclampsia were also evaluated. The HIF protein expression was comparable in these preterm specimens and the normal term placentas. We conclude that protein expression of HIF-2, but not of HIF-1 or -1ß, is selectively increased in the preeclamptic placenta. The molecular mechanism(s) of this abnormality as well as the genes affected downstream are currently under investigation. To our knowledge, this is the first report of abnormal HIF-2 expression in human disease other than cancer.
1 Supported by NIH RO1 HL56410 and PO1 HD30367. Portions of this work were published in abstract form (J Soc Gynecol Invest 2000; 7:287A).
2 Correspondence: Kirk P. Conrad, Magee-Womens Research Institute, 204 Craft Ave., Pittsburgh PA 15213. FAX: 412 641 1503; rsikpc{at}mail.magee.edu
This article has been cited by other articles:
|
|
 |
|
  C Pieh, H Agostini, C Buschbeck, M Kruger, J Schulte-Monting, U Zirrgiebel, J Drevs, and W A Lagreze VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity Br. J. Ophthalmol., May 1, 2008; 92(5): 689 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Papageorghiou, F. Prefumo, K. Leslie, D. C. Gaze, P. O. Collinson, and B. Thilaganathan Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin Hum. Reprod., April 1, 2008; 23(4): 803 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rajakumar, A. Jeyabalan, N. Markovic, R. Ness, C. Gilmour, and K. P. Conrad Placental HIF-1{alpha}, HIF-2{alpha}, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R766 - R774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zamudio, Y. Wu, F. Ietta, A. Rolfo, A. Cross, T. Wheeler, M. Post, N. P. Illsley, and I. Caniggia Human Placental Hypoxia-Inducible Factor-1{alpha} Expression Correlates with Clinical Outcomes in Chronic Hypoxia in Vivo Am. J. Pathol., June 1, 2007; 170(6): 2171 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lockwood, P. Toti, F. Arcuri, E. Norwitz, E. F. Funai, S.-T. J. Huang, L. F. Buchwalder, G. Krikun, and F. Schatz Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for Preeclampsia Am. J. Pathol., April 1, 2007; 170(4): 1398 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lam, K.-H. Lim, and S. A. Karumanchi Circulating Angiogenic Factors in the Pathogenesis and Prediction of Preeclampsia Hypertension, November 1, 2005; 46(5): 1077 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Karumanchi and Y. Bdolah Hypoxia and sFlt-1 in Preeclampsia: The "Chicken-and-Egg" Question Endocrinology, November 1, 2004; 145(11): 4835 - 4837. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Tissot van Patot, J. Bendrick-Peart, V. E. Beckey, N. Serkova, and L. Zwerdlinger Greater vascularity, lowered HIF-1/DNA binding, and elevated GSH as markers of adaptation to in vivo chronic hypoxia Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L525 - L532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Torry, D. Mukherjea, J. Arroyo, and R. J. Torry Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation Reproductive Sciences, May 1, 2003; 10(4): 178 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Casagrandi, C. Bearfield, J. Geary, C.W. Redman, and S. Muttukrishna Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the placental tissue of patients with pre-eclampsia Mol. Hum. Reprod., April 1, 2003; 9(4): 199 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Stepan, W. Marqwardt, Y. Kuhn, M. Hockel, H.-P. Schultheiss, and T. Walther Structure and Regulation of the Murine Mash2 Gene Biol Reprod, January 1, 2003; 68(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang and L.A. Salamonsen Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation Hum. Reprod., February 1, 2002; 17(2): 265 - 274. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
